Lineage Acquires NeuroAirmid and Huntington Program

Lineage Cell Therapeutics completed its acquisition of NeuroAirmid Therapeutics on November 12, adding a neural stem-cell transplantation program being studied in Huntington disease. The SEC filing provides materially more precise consideration and license terms…





